Contact Us
Home Jazz Pharmaceuticals to Present at the UBS Global Life Sciences Conference on September 20

News Release

Media Contact

Kristin Bhavnani
Head of Global Corporate Communications
Jazz Pharmaceuticals plc

Send Email
Ireland: +353 1 637 2141
US: 215-867-4948

Jazz Pharmaceuticals to Present at the UBS Global Life Sciences Conference on September 20

September 14, 2010
PDF Version

PALO ALTO, Calif., Sept 14, 2010 /PRNewswire via COMTEX/ --

Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced today that Bob Myers, the company's president, will present at the UBS Global Life Sciences Conference in New York on Monday, September 20, 2010 at 1:00 p.m. Eastern Time.

A live webcast of the presentation may be accessed from the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com. Please connect to the website prior to the start of the conference call to ensure adequate time for any software downloads that may be necessary to listen to the webcast.

An archived version of the webcast will be available for at least one week on the Investors section of the company's website at www.jazzpharmaceuticals.com.

About Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals (Nasdaq: JAZZ) is a specialty pharmaceutical company that identifies, develops and commercializes innovative treatments for important, underserved markets in neurology and psychiatry. For further information see www.jazzpharmaceuticals.com.

SOURCE Jazz Pharmaceuticals, Inc.